Lin SR, Ke MY, Luo JY, Yuan YZ, Wang JY, diTommaso S, Walter V, Huang J. A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation. World J Gastroenterol 2007; 13(5): 732-739 [PMID: 17278196 DOI: 10.3748/wjg.v13.i5.732]
Corresponding Author of This Article
Jiaqing Huang, MD, PhD, Novartis Pharmaceuticals Corporation, Gastroenterology/Urology Therapeutic Area, Clinical Development and Medical Affairs, One Health Plaza, Building 405/2019, East Hanover, NJ 07936, United States. jiaqing.huang@novartis.com
Article-Type of This Article
Clinical Research
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/